255 related articles for article (PubMed ID: 30779300)
21. Therapeutic Insights in Melasma and Hyperpigmentation Management.
Huerth KA; Hassan S; Callender VD
J Drugs Dermatol; 2019 Aug; 18(8):718-729. PubMed ID: 31424704
[TBL] [Abstract][Full Text] [Related]
22. The treatment of melasma: a review of clinical trials.
Gupta AK; Gover MD; Nouri K; Taylor S
J Am Acad Dermatol; 2006 Dec; 55(6):1048-65. PubMed ID: 17097400
[TBL] [Abstract][Full Text] [Related]
23. Melasma treatment: A novel approach using a topical agent that contains an anti-estrogen and a vascular endothelial growth factor inhibitor.
Cohen PR
Med Hypotheses; 2017 Apr; 101():1-5. PubMed ID: 28351480
[TBL] [Abstract][Full Text] [Related]
24. Melasma and other skin manifestations or oral contraceptives.
Resnik SS
Trans N Engl Obstet Gynecol Soc; 1967; 21():101-7. PubMed ID: 5620604
[TBL] [Abstract][Full Text] [Related]
25. Impact of blue light on skin pigmentation in patients with melasma.
Li L; Jiang X; Tu Y; Yang Y; Zhang X; Gu H; He L
Skin Res Technol; 2023 Jul; 29(7):e13401. PubMed ID: 37522494
[TBL] [Abstract][Full Text] [Related]
26. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.
Olsson H; Borg A; Ewers SB; Fernö M; Möller T; Ranstam J
Med Oncol Tumor Pharmacother; 1986; 3(2):77-81. PubMed ID: 3747639
[TBL] [Abstract][Full Text] [Related]
27. Senescent fibroblasts in melasma pathophysiology.
Kim M; Kim SM; Kwon S; Park TJ; Kang HY
Exp Dermatol; 2019 Jun; 28(6):719-722. PubMed ID: 30575141
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the serum zinc level in adult patients with melasma: Is there a relationship with serum zinc deficiency and melasma?
Rostami Mogaddam M; Safavi Ardabili N; Iranparvar Alamdari M; Maleki N; Aghabalaei Danesh M
J Cosmet Dermatol; 2018 Jun; 17(3):417-422. PubMed ID: 29131489
[TBL] [Abstract][Full Text] [Related]
29. Hormonal milieu in the maintenance of melasma in fertile women.
Hassan I; Kaur I; Sialy R; Dash RJ
J Dermatol; 1998 Aug; 25(8):510-2. PubMed ID: 9769595
[TBL] [Abstract][Full Text] [Related]
30. [The role of sex hormones in the pathogenesis of melasma].
Goandal NF; Rungby J; Karmisholt KE
Ugeskr Laeger; 2022 Feb; 184(6):. PubMed ID: 35179119
[TBL] [Abstract][Full Text] [Related]
31. Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma.
Hernández-Barrera R; Torres-Alvarez B; Castanedo-Cazares JP; Oros-Ovalle C; Moncada B
Clin Exp Dermatol; 2008 May; 33(3):305-8. PubMed ID: 18419607
[TBL] [Abstract][Full Text] [Related]
32. [Physiopathology of melasma].
Miot LD; Miot HA; Silva MG; Marques ME
An Bras Dermatol; 2009; 84(6):623-35. PubMed ID: 20191174
[TBL] [Abstract][Full Text] [Related]
33. Endocrinologic profile of patients with idiopathic melasma.
Pérez M; Sánchez JL; Aguiló F
J Invest Dermatol; 1983 Dec; 81(6):543-5. PubMed ID: 6644096
[TBL] [Abstract][Full Text] [Related]
34. Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.
Rendon MI; Barkovic S
J Drugs Dermatol; 2016 Nov; 15(11):1435-1441. PubMed ID: 28095558
[TBL] [Abstract][Full Text] [Related]
35. Melasma in Latin Americans.
Perez M; Luke J; Rossi A
J Drugs Dermatol; 2011 May; 10(5):517-23. PubMed ID: 21533299
[TBL] [Abstract][Full Text] [Related]
36. Melasma pathogenesis: a review of the latest research, pathological findings, and investigational therapies.
Rajanala S; Maymone MBC; Vashi NA
Dermatol Online J; 2019 Oct; 25(10):. PubMed ID: 31735001
[TBL] [Abstract][Full Text] [Related]
37. Complex segregation analysis of facial melasma in Brazil: evidence for a genetic susceptibility with a dominant pattern of segregation.
Holmo NF; Ramos GB; Salomão H; Werneck RI; Mira MT; Miot LDB; Miot HA
Arch Dermatol Res; 2018 Dec; 310(10):827-831. PubMed ID: 30167816
[TBL] [Abstract][Full Text] [Related]
38. Sex hormones and coronary disease: a review of the clinical studies.
Kalin MF; Zumoff B
Steroids; 1990 Aug; 55(8):330-52. PubMed ID: 2237942
[TBL] [Abstract][Full Text] [Related]
39. Melasma: a comprehensive update: part I.
Sheth VM; Pandya AG
J Am Acad Dermatol; 2011 Oct; 65(4):689-697. PubMed ID: 21920241
[TBL] [Abstract][Full Text] [Related]
40. Estrogen receptor expression in melasma: results from facial skin of affected patients.
Lieberman R; Moy L
J Drugs Dermatol; 2008 May; 7(5):463-5. PubMed ID: 18505139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
